Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes
CNS Neuroscience & Therapeutics · 2025-05 · 31 (5)
DOI: 10.1111/cns.70422 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 15.05.2025. Verfasst von Tianrui Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Clinical Medicine, Jiujiang University, Jiujiang, China. Hauptthemen laut MEDLINE: Pericytes, Blood-Brain Barrier, Central Nervous System Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangxi Provincial Health Commission Science and Technology Plan project, Jiangxi Provincial Administration of Traditional Chinese Medicine science and technology plan project, Youth Foundation of Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Background
Dysfunction of the blood–brain barrier (BBB) is an important pathological mechanism in central nervous system (CNS) diseases and can trigger a series of pathological reactions, such as neuroinflammatory responses, oxidative stress, immune infiltration, etc., thereby worsening brain damage. However, pericytes are often overlooked by researchers, and no review research has yet summarized the mechanism by which pericytes contribute to BBB dysfunction in CNS diseases.
Results
Therefore, this review explores the pathophysiology of BBB dysfunction in CNS diseases and provides a detailed account of the biological characteristics of pericytes, especially the controversy over their biomarkers. Subsequently, we review the role of pericytes in CNS diseases such as Alzheimer's disease, vascular dementia, multiple sclerosis, ischemic stroke, and hemorrhagic stroke, with a particular focus on the role of pericytes in BBB dysfunction. In addition, we also discuss treatments based on pericytes, such as regenerative medicine that induces pericyte differentiation and Pericyte‐Extracellular Vesicles.
Conclusions
This review aims to provide a more comprehensive understanding and guidance on the role of pericytes in BBB dysfunction in CNS diseases and serve clinical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, School of Clinical Medicine, Jiujiang University, Jiujiang, China.
- Jiujiang Clinical Precision Medicine Research Center, Jiujiang, China.
- Department of Medical Laboratory, Affiliated Hospital of Jiujiang University, Jiujiang, China.
- Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang, China.
ORCID-Profile: Tianrui Yu, Zixuan Wang
Förderung
- Jiangxi Provincial Health Commission Science and Technology Plan project
- Jiangxi Provincial Administration of Traditional Chinese Medicine science and technology plan project
- Youth Foundation of Natural Science Foundation of Jiangxi Province
- Research and Reform Project on Education and Teaching in Ordinary Colleges and Universities
- National Natural Science Foundation of China
Zitieren
APA
Yu, T., Wang, Z., Chen, Y., Xiang, Y., Wu, M., Zhang, M., Yin, X., & Chen, Z. (2025). Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes. CNS Neuroscience & Therapeutics, 31(5). https://doi.org/10.1111/cns.70422
Vancouver
Yu T, Wang Z, Chen Y, Xiang Y, Wu M, Zhang M, et al. Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes. CNS Neuroscience & Therapeutics. 2025;31(5). doi:10.1111/cns.70422
BibTeX
@article{Yu2025,
author = {Yu, Tianrui and Wang, Zixuan and Chen, Yanghang and Xiang, Yuanyuan and Wu, Moxin and Zhang, Manqing and Yin, Xiaoping and Chen, Zhiying},
title = {Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {5},
doi = {10.1111/cns.70422}
}
EUVIMED